KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Long-Term Debt Repayments (2019 - 2022)

Twist Bioscience (TWST) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $3.1 million as the latest value for Q2 2022.

  • Quarterly Long-Term Debt Repayments rose 274.07% to $3.1 million in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $3.1 million through Mar 2023, up 2785.19% year-over-year, with the annual reading at $1.6 million for FY2022, 53.26% down from the prior year.
  • Long-Term Debt Repayments for Q2 2022 was $3.1 million at Twist Bioscience, up from -$11.6 million in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $10.0 million in Q4 2021, with the low at -$11.6 million in Q1 2022.
  • Average Long-Term Debt Repayments over 4 years is $760846.2, with a median of $833000.0 recorded in 2019.
  • The sharpest move saw Long-Term Debt Repayments soared 1300.48% in 2021, then plummeted 562.32% in 2022.
  • Over 4 years, Long-Term Debt Repayments stood at $833000.0 in 2019, then plummeted by 200.0% to -$833000.0 in 2020, then skyrocketed by 1300.48% to $10.0 million in 2021, then tumbled by 68.84% to $3.1 million in 2022.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $3.1 million, -$11.6 million, and $10.0 million for Q2 2022, Q1 2022, and Q4 2021 respectively.